When Names Make Claims: Ethical Issues in Medical Device Marketing

By Bramstedt, Katrina A. | Ethics & Medicine, Summer 2004 | Go to article overview

When Names Make Claims: Ethical Issues in Medical Device Marketing


Bramstedt, Katrina A., Ethics & Medicine


Introduction

"Image is Everything," or so says the camera division of Canon, Inc. Product branding is ultimately about creating a relationship with the customer, and in the case of the direct-to-consumer advertising strategies of pharmaceuticals, the customer is both the physician and the patient. Even if a product is stripped of its print, radio, or television advertising, the name of the product itself is an advertisement. Thus said, the name of a product and the image it conjures are relevant to its marketing to consumers.

In the United States, the generic and trade names (also known as brand names) of pharmaceuticals are formally evaluated prior to marketing; however, there is no formal process of name analysis for medical device brand names (personal communication, US Food and Drug administration, 28 March 2003). Generic drug names are created and assigned by the United States Adopted Names Council, which establishes logical nomenclature classifications based on pharmacological and/or chemical relationships (for example, angiotensin-converting-enzyme inhibitors end in "pril"). Generic names are then sent to the International Nonproprietary Name Committee of the World Health Organization for review and approval. Generic names must not be misleading or confusing (similar to other drug names), or imply efficacy or application to particular anatomical parts.1

Trade names are first sent to the United States Patent and Trademark Office (PTO) for evaluation. The PTO review focuses only on assigning legal rights to a brand name and is not permitted to include an evaluation of the name with regard to its potential to cause clinical confusion in prescribing or use. Once approved by the PTO, the drug's trade name is then reviewed by the Food and Drug Administration Office of Postmarketing Drug Risk Assessment. Part of this requirement stems from the fact that critical errors can occur when two or more drugs have similar sounding names, names that are difficult to pronounce, or names that can be easily misspelled and interpreted as other drugs. Between 1993 and 1998, 52 deaths were reported in the US as caused by drug name errors (mixups made by medical professionals or patients due to drug name confusion).2 The confusion that comes from phonologically similar names for different drugs (see Table 1) can lead to clinical complications, should patients mistakenly take the wrong medication. Also, since certain letters of the alphabet (W, M, N, C, L, O) are susceptible to blurring or confusion when handwritten, there is concern about using such letters in drug trade names.3 An additional consideration is the potential for a drug trade name to impart notions of composition, quality, safety, and performance. Approximately one-third of the names submitted yearly to the Food and Drug Administration are rejected (www.fda.gov).

The international marketing of drugs can also pose potential problems. If a drug is intended to be marketed in both the US and the European Union, its trade name is also reviewed by European patent and trademark offices. The European Union's Invented Name Review Group (London, UK) reviews all manufacturer-submitted potential trade names to ensure that the names do not convey "misleading therapeutic or pharmaceutical connotations," that they are not misleading with regard to the composition of the product, and that they are not prone to cause "confusion in print, handwriting, or speech" with regard to an existing product.4 As in the case of Prostin, multiple chemical compounds (with different functions and side effects) can have the same trade name across various countries, leading to prescribing problems for travelers or physicians who relocate their practice.5 Conversely, some drugs have different trade names throughout the world (Table 2) because some names may not be appealing in certain countries for linguistic (difficult pronunciations) or cultural (negative associations with the word in either formal, conversational, or street/slang usage) reasons.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

When Names Make Claims: Ethical Issues in Medical Device Marketing
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.